中文名稱： *效價測定,CAS：114-07-8
英文名稱： Erythromycin
英文別名： Abomacetin; Ak-Mycin; Aknin; Drmysin; E-Base; E.E.S; Emgel; EMU; E-mycin; Ergel; Eritocina; Eritrocina; Erthrogran; Eryacne; ERYC; Erycen; Erycette; Erycin; Erycinum; Ery Derm; Erymax; ERY-PED; ERY-TAB; Erythro; Erythroguent; Erythromast; Erythromast 36; Erythromid; Ilocap; Ilosone; Ilotycin; Inderm; L-alpha-Egg-phosphatidylcholine; P.C.E.; Pediamycin; Retcin; Robimycin; Statcin; Staticin; Stiemycin; Torlamicina; Torlamicna; T-Stat; Wintrocin; Wyamycin-s; 6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name); (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl propanoate (non-preferred name); (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name); (3R,7R,9R,11R,13S,14R)-6-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name); abboticin
CAS號： 114-07-8
EINECS號： 204-040-1
分子式： C37H67NO13
分子量： 733.9268
規 格： 20mg
InChI： InChI=1/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21?,22-,23+,24+,25-,26+,28-,29?,30?,31+,32?,34?,35-,36-,37-/m1/s1
分子結構： * 114-07-8
密度： 1.2g/cm3
熔點： 138-140℃
沸點： 818.4°C at 760 mmHg
閃點： 448.8°C
蒸汽壓： 4.94E-31mmHg at 25°C
物化性質：
熔點：138 - 140
產品用途：
本品為大環內酯類抗生素衍生物中間體屬抑菌型抗生素，抗菌譜與青菌素相似
危險性標志: Xn:Harmful;
風險術語： R42/43:;
安全術語： S24:;
S37:;
S45:;
*效價測定,CAS：114-07-8突破傳統技術，延續經典方法，打造全新、*、實用、方便的好試劑，堅守做好每一個產品。時時更新產品數據，分享國內外相關產品學術研究動態，更多相關信息可來電我司客服人員，獲得優惠信息，實驗有方法，省錢有妙招，讓您大展宏圖。
儲存條件： 避光、干燥陰涼處封閉貯存,嚴禁與有毒、有害物品混放、混運。本品為非危險產品可按一般化學品運輸,輕搬動輕放,防止日曬、雨淋！受熱、受潮、受光后易喪失活力,保存期短,因此貯存和運輸條件比較苛刻...
